- Trials with a EudraCT protocol (23)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
23 result(s) found for: Alpha D Glucose.
Displaying page 1 of 2.
EudraCT Number: 2020-002312-43 | Sponsor Protocol Number: 01052020 | Start Date*: 2020-05-28 |
Sponsor Name:Miguel Cervero Jiménez, servicio de Medicina Interna, Hospital Universitario Severo Ochoa | ||
Full Title: Clinical trial, PHASE III, randomized, open-label, to evaluate the efficacy of administering high-dose cholecalciferol orally alongside standard therapy in patients with COVID-19 pneumonia (COVID-1... | ||
Medical condition: COVID-19 PNEUMONIA | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-006114-14 | Sponsor Protocol Number: 62326B1658 | Start Date*: 2012-04-17 |
Sponsor Name:Research and Development department | ||
Full Title: “Effects of testosterone on glycaemic control and other Cardiovascular Risk factors in Hypogonadal Men with uncontrolled Type 2 Diabetes: A randomized double – blinded placebo controlled add on tr... | ||
Medical condition: Hypogonadism Type 2 Diabetes Cardiovascular risk | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002801-20 | Sponsor Protocol Number: NN1250-4252 | Start Date*: 2017-02-10 | |||||||||||
Sponsor Name:Novo Nordisk A/S | |||||||||||||
Full Title: A trial comparing the efficacy and safety of insulin degludec and insulin glargine 300 units/mL in subjects with type 2 diabetes mellitus inadequately treated with basal insulin with or without ora... | |||||||||||||
Medical condition: Diabetes Mellitus, Type 2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) HU (Completed) DK (Completed) EE (Completed) GR (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005549-30 | Sponsor Protocol Number: ESR-15-11421 | Start Date*: 2016-02-17 | |||||||||||
Sponsor Name:Dept of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University | |||||||||||||
Full Title: A single-dose cross-over study to assess direct and indirect effects of dapagliflozin on pancreatic alpha and beta cells in patients with type 2 diabetes | |||||||||||||
Medical condition: Effects on pancreatic alpha and beta cells in patients with type 2 diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005192-18 | Sponsor Protocol Number: A5351022 | Start Date*: 2007-03-15 | |||||||||||
Sponsor Name:Pfizer Ltd. | |||||||||||||
Full Title: A 1-YEAR, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CP-945,598 IN THE TREATMENT OF OVERWEIGHT, ORAL AGENT-TREATED SUBJECTS WITH TYPE 2 DIABET... | |||||||||||||
Medical condition: Obesity | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) GB (Prematurely Ended) DE (Prematurely Ended) SK (Completed) SE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011003-23 | Sponsor Protocol Number: GFT505-209-4 | Start Date*: 2009-05-28 | ||||||||||||||||
Sponsor Name:GENFIT | ||||||||||||||||||
Full Title: A Pilot study to evaluate the Efficacy and Safety of GFT505 (80mg) orally administered once daily for 35 days in patients presenting with impaired glucose tolerance and abdominal obesity. A double ... | ||||||||||||||||||
Medical condition: patients presenting with impaired glucose tolerance and abdominal obesity | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-004234-42 | Sponsor Protocol Number: NN9535-4650 | Start Date*: 2020-03-11 | |||||||||||
Sponsor Name:Novo Nordisk A/S | |||||||||||||
Full Title: Effect and safety of two different dose-escalation regimens for once-weekly semaglutide s.c. in subjects with type 2 diabetes mellitus previously treated with GLP-1 RAs | |||||||||||||
Medical condition: Diabetes Mellitus, Type 2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Prematurely Ended) AT (Prematurely Ended) SE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000671-16 | Sponsor Protocol Number: BC28027 | Start Date*: 2013-02-06 | |||||||||||||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||||||||||||
Full Title: A Phase 3b Study To Evaluate The Potential Of Aleglitazar To Reduce Cardiovascular Risk In Patients With Stable Cardiovascular Disease And Glucose Abnormalities | |||||||||||||||||||||||
Medical condition: - Stable Cardiovascular Disease and - Diabetes Mellitus Type 2 or Pre-diabetes | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Prematurely Ended) SE (Prematurely Ended) CZ (Prematurely Ended) HU (Prematurely Ended) LT (Prematurely Ended) AT (Prematurely Ended) EE (Prematurely Ended) LV (Prematurely Ended) IT (Prematurely Ended) ES (Prematurely Ended) FI (Prematurely Ended) PL (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-007971-18 | Sponsor Protocol Number: LOC/05-12/RENNES | Start Date*: 2008-03-18 | |||||||||||||||||||||
Sponsor Name:C.H.U. de RENNES | |||||||||||||||||||||||
Full Title: Evaluation des effets de la 9 alpha fluorohydrocortisone sur la réponse pressive à la noradrénaline, la perfusion gastrique, le débit huméral et la rigidité artérielle dans le choc septique. | |||||||||||||||||||||||
Medical condition: Choc septique. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000488-83 | Sponsor Protocol Number: P03685 | Start Date*: 2004-11-29 |
Sponsor Name:Schering Plough Research Institute, a Division of Schering Corporation | ||
Full Title: A Study to Assess Treatment with PEG-Intron® and Rebetol® in Naïve Patients with Genotype 1 Chronic Hepatitis C and Slow Virological Response | ||
Medical condition: Chronic Hepatitis C, Genotype 1 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) SE (Completed) HU (Completed) LT (Completed) CZ (Completed) AT (Completed) DK (Completed) GB (Completed) ES (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-004034-32 | Sponsor Protocol Number: 17-216 | Start Date*: 2006-09-20 |
Sponsor Name:Medizinische Universität Graz | ||
Full Title: Zur Frage des neuroleptikainduzierten metabolischen Syndroms. Studie 1: Fettverteilung und spezifische hormonelle Parameter. Eine prospektive Vergleichsstudie zwischen 5 atypischen Neuroleptika | ||
Medical condition: Einschlusskriterien: - Schizophrenie, schizoaffektive Störung oder akut polymorph psychotische Störung - Alter: zwischen 18 und 70 Jahren - Vorliegen einer schriftlichen Einverständniserklärung zu... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-003721-18 | Sponsor Protocol Number: CV181365 | Start Date*: 2015-09-14 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A 52-week International, Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel Group, Phase 3bTrial with a Blinded 104-week Long -term Extension Period to Evaluate the Efficacy and Saf... | |||||||||||||
Medical condition: Inadequately controlled Diabetes Mellitus Type 2. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) DE (Completed) HU (Completed) SE (Completed) PL (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000476-38 | Sponsor Protocol Number: NN1436-4481 | Start Date*: 2021-03-01 | |||||||||||
Sponsor Name:Novo Nordisk A/S | |||||||||||||
Full Title: Effectiveness and safety of once weekly insulin icodec used with DoseGuide versus once daily basal insulin analogues in an insulin naïve type 2 diabetes population in a clinical practice setting | |||||||||||||
Medical condition: Diabetes Mellitus, Type 2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) HU (Completed) GR (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001983-20 | Sponsor Protocol Number: NGLU-CL01-T | Start Date*: 2015-08-06 | ||||||||||||||||
Sponsor Name:Alexion Pharmaceuticals, Inc | ||||||||||||||||||
Full Title: A Phase I/II Open Label Study in Previously Studied, SBC-103 Treatment Naïve MPS IIIB Subjects to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 Administered Int... | ||||||||||||||||||
Medical condition: Mucopolysaccharidosis III, type B (MPS IIIB), Sanfilippo B | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-001102-17 | Sponsor Protocol Number: CV181363 | Start Date*: 2015-03-27 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A 26-week International, Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel Group, Phase 3bTrial with a Blinded 26-week Long -term Extension Period to Evaluate the Efficacy and Safe... | |||||||||||||
Medical condition: Type 2 Diabetes Mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-004474-15 | Sponsor Protocol Number: PETFLUTEMETAMOL-FDG/BBRC2015 | Start Date*: 2016-03-14 | ||||||||||||||||
Sponsor Name:BarcelonaBeta Brain Research Center | ||||||||||||||||||
Full Title: Characterization of cerebral amyloid deposition with 18F-Flutemetamol PET and of glucose metabolism with 18F-FDG PET in individuals enrolled in the ALFA project | ||||||||||||||||||
Medical condition: Study to understand factors related with the preclinical stages of Alzheimer's Disease and investigate markers that predict its progression. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-005287-21 | Sponsor Protocol Number: Simon1234 | Start Date*: 2023-06-01 | |||||||||||
Sponsor Name:Rigshospitalet, Center for Aktiv Sundhed, section 7641 | |||||||||||||
Full Title: Exercise-induced cardiac adaptions in rheumatoid arthritis patients during interleukin-6 vs. tumor necrosis factor antibody therapy: a randomised controlled study (RABEX). | |||||||||||||
Medical condition: Rheumatoid Athritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002560-16 | Sponsor Protocol Number: 747-303 | Start Date*: 2015-12-10 | |||||||||||
Sponsor Name:Intercept Pharmaceuticals Inc. | |||||||||||||
Full Title: A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis | |||||||||||||
Medical condition: Nonalcoholic steatohepatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Prematurely Ended) AT (Completed) SE (Completed) BE (Completed) DK (Completed) ES (Prematurely Ended) FI (Completed) PT (Prematurely Ended) HU (Completed) PL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002528-42 | Sponsor Protocol Number: 0431-083 | Start Date*: 2011-12-30 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp. A subsidiary of Merck & Co. Inc | |||||||||||||
Full Title: A Phase III, Multicenter, Double-Blind, Randomized, Placebo- and Metformin-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Sitagliptin in Pediatric Patients with Type 2 Diabetes Me... | |||||||||||||
Medical condition: Type 2 Diabetes Mellitus | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Completed) LT (Completed) DE (Completed) ES (Prematurely Ended) IT (Completed) BG (Completed) AT (Completed) DK (Completed) SE (Completed) HU (Completed) PL (Completed) SK (Completed) Outside EU/EEA GR (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003400-39 | Sponsor Protocol Number: NGLU-CL02 | Start Date*: 2014-07-15 | ||||||||||||||||
Sponsor Name:Alexion Pharmaceuticals, Inc. | ||||||||||||||||||
Full Title: A Phase I/II Open Label Study in MPS IIIB Subjects to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 Administered Intravenously | ||||||||||||||||||
Medical condition: Mucopolysaccharidosis III, type B (MPS IIIB), Sanfilippo B | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) ES (Temporarily Halted) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.